Ottimo Pharma Emerges With An Ex-Seagen CEO And A PD1/VEGF Bispecific Contender

 
• By Andrew McConaghie
  
Cancer cells on scientific background.3d illustration
• Source: Shutterstock

More from Start-Ups & SMEs

More from Scrip